Analystreport

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $97.00 price target on the stock.

Intercept Pharmaceuticals, Inc.  (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations